Home HPV self-sampling with supportive 3R counseling for women with HIV in Ghana
The Impact of an Evidence-Based, Behavioral Cervical Cancer Screening Intervention among Women Living with HIV in Ghana (HOPE-inG): A Type 2 Hybrid Effectiveness Implementation Trial
This project offers HPV self-sampling plus a brief 3R communication approach to help women living with HIV in Ghana get timely cervical cancer screening.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor University NIH-funded |
| Lab location | 1 site (Waco, United States) |
| Project ID | NIH-11398288 on NIH RePORTER |
What this research studies
You would be offered a HPV self-sampling kit to use at home together with a short, supportive communication session using a Reframing-Reprioritizing-Reforming (3R) approach. Women receiving HOPE will be compared with those getting routine clinic-based screening at selected secondary-level health facilities. The team will work with four hospitals to adapt and test strategies that help clinics adopt and keep offering the self-sampling approach. The trial measures both how well the approach gets patients screened and how to make it part of regular care.
Who could benefit from this research
Good fit: Women living with HIV who are eligible for cervical cancer screening and receive care at participating secondary-level health facilities in Ghana are the ideal candidates.
Not a fit: People who are not living with HIV, not eligible for cervical screening, already up-to-date on screening, or living outside the participating Ghana clinics are unlikely to benefit from joining this project.
Why it matters
Potential benefit: If successful, this could make screening easier to access and substantially increase early detection of cervical pre-cancer and cancer among women with HIV.
How similar studies have performed: A previous randomized trial in Ghana showed the HOPE approach greatly increased screening uptake compared with routine clinic screening, though larger-scale implementation has not yet been tested.
Where this research is happening
Waco, United States
- Baylor University — Waco, United States (Active)
Researchers
- Principal investigator: Asare, Matthew — Baylor University
- Study coordinator: Asare, Matthew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.